All Headlines >>
This, says the company, highlights the need for increased awareness of MCTs, which, accounting for up to 21% of skin cancer cases2 in dogs, are the most common form of canine cutaneous neoplasia.
The incidence of MCTs is highest in dogs aged 6 to 10 years old3,4 with predisposition in some of the UK’s most popular breeds such as Labradors, French Bulldogs, Staffordshire Bull Terriers and Golden Retrievers.
Virbac says that until the launch of Stelfonta, surgical removal of tumours was the standard of care, but surgery can pose challenges for the veterinary surgeon, such as the accessibility of the tumour in order to obtain sufficient margins and anaesthetic risks, particularly in senior and brachycephalic pets.
Apparently, however, 77% of delegates at London Vet Show said they were either likely or very likely to use Stelfonta on their next mast cell tumour case.
To help veterinary professionals and pet owners identify skin masses, Virbac has created a range of resources available at: vet-uk.virbac.com/stelfonta/education.
PS: Whilst you're here, take a moment to see our latest job opportunities for vet nurses.
Veterinary Nurse Jobs and
Veterinary Nurse Locums |
Follow VN Jobs on Facebook | Linkedin | Twitter | Contact
Contact us for more information about the advertising and editorial opportunities on VetNurse.co.uk
Veterinary Forums | Veterinary Nursing News | Veterinary Galleries
Anaesthesia & Analagesia | Animal Behaviour | Dentistry | Dermatology | Veterinary Diagnostic Imaging | Equine Nursing | Exotics | Emergency & Critical Care | Lab/Clinical Pathology | Medical Nursing | Physiotherapy | Surgical Nursing | Wound Management